Navigation Links
R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
Date:3/10/2009

WASHINGTON, March 10 /PRNewswire-USNewswire/ -- Despite the nation's economic slowdown, America's pharmaceutical research and biotechnology companies invested a record $65.2 billion last year in the research and development of new life-changing medicines and vaccines - an increase of roughly $2 billion from 2007, according to analyses by the Pharmaceutical Research and Manufacturers of America (PhRMA) and Burrill & Company.

PhRMA-member companies alone invested an estimated $50.3 billion on pharmaceutical R&D last year - up from the previous record of $47.9 billion in 2007, according to the PhRMA survey. Additionally, the Burrill & Company analysis shows that non-PhRMA pharmaceutical research companies spent an estimated $14.9 billion on R&D last year.

This record R&D investment reflects the continued commitment of America's pharmaceutical research and biotechnology companies (also known collectively as the biopharmaceutical sector) to lead the world in the pursuit of new, life-saving and life-enhancing medicines. The foremost beneficiaries of this dedication are patients, who are living longer, healthier, more productive lives, thanks in part to the new medicines generated by these research efforts.

While the innovative process, which is costly, time-consuming and risky, has always presented challenges, the current economic climate compounds those challenges. However, the data show that the drive toward innovation remains strong.

The sector's R&D focus also provides considerable value to the U.S. economy. At a time when many industries are seeking help just to stay afloat, pharmaceutical research companies are devoting the vast majority of their R&D investment within America. In fact, PhRMA member companies dedicated roughly 70 percent of their R&D investment domestically.

The sector's contribution to the nation's economy is further illu
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Roche,s Bloodhound technology is on ... in hematology testing, according to Kalorama Information.  The ... of its Bloodhound digital cell imaging technology –as ... hematology analyzer – is notable as a ... current leader CellaVision, but also compete more broadly ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced the addition of ... - Forecast to 2020" report to their offering. ... in 2020 from an estimated $7.1 Billion in 2015, growing at ... North America , followed by Europe ... World (RoW). The cancer diagnostics market in Asia ...
(Date:7/2/2015)... Numotion,s Board of Directors and Mike ... Feitel has joined the Company as Chief Financial ... successful 18 year career at GE serving in executive ... productivity to result in significant industry leading growth and ... Officer for GE Healthcare Global Services, a $5B P&L ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Numotion Names Tamas Feitel Chief Financial Officer 2
... the leading developer of radiology workflow solutions, today ... a joint venture between Inland Imaging and Providence ... system with Medicalis, federated productivity and quality platform ... these two proven solutions will enable radiologists who ...
... 2010 Orion HealthCorp , Inc., a leader in ... announced today that its President and CEO, Terrence L. Bauer, ... 25 Entrepreneur list. Bauer ranked No. 12 on the list. ... Ingwersen, Business-to-Business compiles the list each year, recognizing ...
Cached Medicine Technology:Medicalis Acquires RadWorkFlow from Inland Imaging and Providence Health Care 2Medicalis Acquires RadWorkFlow from Inland Imaging and Providence Health Care 3Business-to-Business Magazine Names Orion HealthCorp CEO as Top 25 Entrepreneur for 2010 2
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Mississippi. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... Avenue, New Albany, MS 38652, will have a grand opening event on July 4, ...
(Date:7/2/2015)... ... , ... Following the recent report by JAMA Internal Medicine published ... Americans, Samir Becic emphatically declared a war on obesity in the United States. , ... "We must understand the magnitude of this discovery. For that reason, I am declaring, ...
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was ... and coolest technology products available to consumers. Amanda Forstrom, a technology expert and special ... are the most versatile smart light bulbs on the market. , According to the ...
(Date:7/2/2015)... ... , ... Global leader and compression innovator, SIGVARIS North America, is ... For style that’s quick on its feet, men will love this fun new way ... everywhere because a simple change in socks can dramatically help improve overall leg health ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3
... Manufacturers, sales of OTC drugs grew by 2.4% ... 2008, according to the latest research in Nonprescription ... worldwide consulting and research firm Kline & Company.Private-label OTC ... within which antacids and allergy medicines posted the highest ...
... derive from problems with cellular respiration, the process through ... Swedish medical university Karolinska Institutet have now discovered a ... popularly called the cell,s power station that plays ... we take a breath, our blood transports oxygen to ...
... for less-expensive medical care , , WEDNESDAY, April 8 (HealthDay News) ... jetting to Bangkok for his first colonoscopy. , ... shortage of nurses, who verified his identity 15 times before ... secondary motive: He is founder and president of Companion Global ...
... Caremark plan participants have access to most comprehensive Spanish-language ... 8 CVS Caremark (NYSE: CVS ) ... Caremark.com. The Web site makes it easier for ... health care by providing them with online information and ...
... Bachelorette, Decides Her Family is Complete After the Birth of ... -- After the arrival of her second child (a ... Trista Sutter, the star of ABC,s first Bachelorette show, has ... last child for the couple. Trista plans to get the ...
... April 8 Amoena, the worldwide leader ... introduction of The Hannah Collection, the industry,s ... and Aloe to ease discomfort after breast ... )(Photo: http://www.newscom.com/cgi-bin/prnh/20090408/CL96087 ...
Cached Medicine News:Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 2Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 3Health News:Key protein in cellular respiration discovered 2Health News:Traveling for Treatment 2Health News:Traveling for Treatment 3Health News:Traveling for Treatment 4Health News:CVS Caremark Launches Spanish Version of Caremark.com 2Health News:CVS Caremark Launches Spanish Version of Caremark.com 3Health News:Trista Sutter Announces She Will Get the Essure Permanent Birth Control Procedure 2Health News:Trista Sutter Announces She Will Get the Essure Permanent Birth Control Procedure 3Health News:Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: